Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 92


Location of recurrences in high-risk stage Iendometrial cancer patients not given postoperative radiotherapy: A Danish gynecological cancer group study.

Ørtoft G, Høgdall C, Juhl C, Petersen LK, Hansen ES, Dueholm M.

Int J Gynecol Cancer. 2019 Mar;29(3):497-504. doi: 10.1136/ijgc-2018-000056. Epub 2019 Jan 4.


The effect of introducing pelvic lymphadenectomy on survival and recurrence rates in Danish endometrial cancer patients at high risk: a Danish Gynecological Cancer Group study.

Ørtoft G, Høgdall C, Juhl C, Petersen LK, Hansen ES, Dueholm M.

Int J Gynecol Cancer. 2019 Jan;29(1):68-76. doi: 10.1136/ijgc-2018-000023.


Detection of high-risk human papillomavirus DNA in tissue from primary cervical cancer tumor, pelvic lymph nodes and recurrent disease.

Fuglsang K, Blaakaer J, Petersen LK, Mejlgaard E, Hammer A, Steiniche T.

Papillomavirus Res. 2018 Dec 14;7:15-20. doi: 10.1016/j.pvr.2018.12.001. [Epub ahead of print]


Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine - A combined analysis of five phase III clinical trials.

Petersen LK, Restrepo J, Moreira ED Jr, Iversen OE, Pitisuttithum P, Van Damme P, Joura EA, Olsson SE, Ferris D, Block S, Giuliano AR, Bosch X, Pils S, Cuzick J, Garland SM, Huh W, Kjaer SK, Bautista OM, Hyatt D, Maansson R, Moeller E, Qi H, Roberts C, Luxembourg A.

Papillomavirus Res. 2017 Jun;3:105-115. doi: 10.1016/j.pvr.2017.03.002. Epub 2017 Mar 16.


Athero-inflammatory nanotherapeutics: Ferulic acid-based poly(anhydride-ester) nanoparticles attenuate foam cell formation by regulating macrophage lipogenesis and reactive oxygen species generation.

Chmielowski RA, Abdelhamid DS, Faig JJ, Petersen LK, Gardner CR, Uhrich KE, Joseph LB, Moghe PV.

Acta Biomater. 2017 Jul 15;57:85-94. doi: 10.1016/j.actbio.2017.05.029. Epub 2017 May 15.


[Possible side effects from HPV vaccination in Denmark].

Hammer A, Petersen LK, Rolving N, Boxill MF, Kallesøe KH, Becker S, Fredberg U, Sørensen VN, Rask CU, Fink PK, Blaakær J.

Ugeskr Laeger. 2016 Jun 27;178(26). pii: V03160205. Review. Danish.


[Pregnant women can also get cancer].

Petersen LK, Uldbjerg N.

Ugeskr Laeger. 2016 Apr 18;178(16):V67479. Danish. No abstract available.


Amphiphilic macromolecule nanoassemblies suppress smooth muscle cell proliferation and platelet adhesion.

Chan JW, Lewis DR, Petersen LK, Moghe PV, Uhrich KE.

Biomaterials. 2016 Apr;84:219-229. doi: 10.1016/j.biomaterials.2015.12.033. Epub 2016 Jan 4.


Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques.

Lewis DR, Petersen LK, York AW, Ahuja S, Chae H, Joseph LB, Rahimi S, Uhrich KE, Haser PB, Moghe PV.

Cardiovasc Res. 2016 Feb 1;109(2):283-93. doi: 10.1093/cvr/cvv237. Epub 2015 Oct 14.


Safety and immunogenicity of a 9-valent HPV vaccine in females 12-26 years of age who previously received the quadrivalent HPV vaccine.

Garland SM, Cheung TH, McNeill S, Petersen LK, Romaguera J, Vazquez-Narvaez J, Bautista O, Shields C, Vuocolo S, Luxembourg A.

Vaccine. 2015 Nov 27;33(48):6855-64. doi: 10.1016/j.vaccine.2015.08.059. Epub 2015 Sep 26.


A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9-15-Year-Old Girls.

Vesikari T, Brodszki N, van Damme P, Diez-Domingo J, Icardi G, Petersen LK, Tran C, Thomas S, Luxembourg A, Baudin M.

Pediatr Infect Dis J. 2015 Sep;34(9):992-8. doi: 10.1097/INF.0000000000000773.


A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.

Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, Moreira ED Jr, Ngan Y, Petersen LK, Lazcano-Ponce E, Pitisuttithum P, Restrepo JA, Stuart G, Woelber L, Yang YC, Cuzick J, Garland SM, Huh W, Kjaer SK, Bautista OM, Chan IS, Chen J, Gesser R, Moeller E, Ritter M, Vuocolo S, Luxembourg A; Broad Spectrum HPV Vaccine Study.

N Engl J Med. 2015 Feb 19;372(8):711-23. doi: 10.1056/NEJMoa1405044.


Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo.

Lewis DR, Petersen LK, York AW, Zablocki KR, Joseph LB, Kholodovych V, Prud'homme RK, Uhrich KE, Moghe PV.

Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2693-8. doi: 10.1073/pnas.1424594112. Epub 2015 Feb 17.


Role of human papillomavirus testing and cytology in follow-up after conization.

Gosvig CF, Huusom LD, Deltour I, Andersen KK, Duun-Henriksen AK, Madsen EM, Petersen LK, Elving L, Schouenbourg L, Iftner A, Svare E, Iftner T, Kjaer SK.

Acta Obstet Gynecol Scand. 2015 Apr;94(4):405-11. doi: 10.1111/aogs.12601. Epub 2015 Feb 27.


Addressing challenges in future surveillance after surgery for early-stage cervical cancer.

Fuglsang K, Petersen LK, Blaakaer J.

Int J Gynecol Cancer. 2015 Feb;25(2):309-14. doi: 10.1097/IGC.0000000000000346.


Pulmonary biodistribution and cellular uptake of intranasally administered monodisperse particles.

Brenza TM, Petersen LK, Zhang Y, Huntimer LM, Ramer-Tait AE, Hostetter JM, Wannemuehler MJ, Narasimhan B.

Pharm Res. 2015 Apr;32(4):1368-82. doi: 10.1007/s11095-014-1540-y. Epub 2014 Oct 9.


[Gynaecological cancer patients' view on follow-up programmes differ from health professionals'].

Dahl L, Væggemose U, Blaakaer J, Petersen LK, Wittrup I.

Ugeskr Laeger. 2014 Jul 28;176(31):1855-8. Danish.


Impact of hydrophobic chain composition on amphiphilic macromolecule antiatherogenic bioactivity.

Faig A, Petersen LK, Moghe PV, Uhrich KE.

Biomacromolecules. 2014 Sep 8;15(9):3328-37. doi: 10.1021/bm500809f. Epub 2014 Aug 6.


Paradoxes of follow-up - health professionals' views on follow-up after surgical treatment in gynecological cancer.

Dahl L, Wittrup I, Petersen LK, Blaakaer J, Væggemose U.

Acta Oncol. 2015 Feb;54(2):194-9. doi: 10.3109/0284186X.2014.935475. Epub 2014 Jul 14.


Supplemental Content

Loading ...
Support Center